The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
- PMID: 18256187
- PMCID: PMC2268178
- DOI: 10.1073/pnas.0711976105
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
Abstract
CD4(+) Th1 type immunity is implicated in resistance to global infectious diseases. To improve the efficacy of T cell immunity induced by human immunodeficiency virus (HIV) vaccines, we are developing a protein-based approach that directly harnesses the function of dendritic cells (DCs) in intact lymphoid tissues. Vaccine proteins are selectively delivered to DCs by antibodies to DEC-205/CD205, a receptor for antigen presentation. We find that polyriboinosinic:polyribocytidylic acid (poly IC) independently serves as an adjuvant to allow a DC-targeted protein to induce protective CD4(+) T cell responses at a mucosal surface, the airway. After two doses of DEC-targeted, HIV gag p24 along with poly IC, responder CD4(+) T cells have qualitative features that have been correlated with protective function. The T cells simultaneously make IFN-gamma, tumor necrosis factor (TNF)-alpha, and IL-2, and in high amounts for prolonged periods. The T cells also proliferate and continue to secrete IFN-gamma in response to HIV gag p24. The adjuvant role of poly IC requires Toll-like receptor (TLR) 3 and melanoma differentiation-associated gene-5 (MDA5) receptors, but its analog poly IC(12)U requires only TLR3. We suggest that poly IC be tested as an adjuvant with DC-targeted vaccines to induce numerous multifunctional CD4(+) Th1 cells with proliferative capacity.
Conflict of interest statement
Conflict of interest statement: R.M.S. is a consultant to Celldex, which is developing human DEC-205-based vaccines. All other authors declare no conflict of interest.
Figures





Similar articles
-
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.J Exp Med. 2009 Jul 6;206(7):1589-602. doi: 10.1084/jem.20090247. Epub 2009 Jun 29. J Exp Med. 2009. PMID: 19564349 Free PMC article.
-
Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.J Intern Med. 2012 Feb;271(2):183-92. doi: 10.1111/j.1365-2796.2011.02496.x. Epub 2012 Jan 4. J Intern Med. 2012. PMID: 22126373 Free PMC article. Review.
-
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.J Exp Med. 2006 Mar 20;203(3):607-17. doi: 10.1084/jem.20052005. Epub 2006 Feb 27. J Exp Med. 2006. PMID: 16505141 Free PMC article.
-
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.Adv Drug Deliv Rev. 2013 Oct;65(10):1386-99. doi: 10.1016/j.addr.2013.05.013. Epub 2013 Jun 7. Adv Drug Deliv Rev. 2013. PMID: 23751781 Review.
-
Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.J Immunol. 2013 Nov 15;191(10):5085-96. doi: 10.4049/jimmunol.1301730. Epub 2013 Oct 2. J Immunol. 2013. PMID: 24089189 Free PMC article.
Cited by
-
DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?Immunology. 2015 Aug;145(4):519-33. doi: 10.1111/imm.12467. Epub 2015 Apr 30. Immunology. 2015. PMID: 25819746 Free PMC article.
-
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.Nat Rev Immunol. 2012 Jun 22;12(7):479-91. doi: 10.1038/nri3247. Nat Rev Immunol. 2012. PMID: 22728526 Review.
-
An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models.Clin Vaccine Immunol. 2013 Jan;20(1):85-94. doi: 10.1128/CVI.00552-12. Epub 2012 Nov 14. Clin Vaccine Immunol. 2013. PMID: 23155123 Free PMC article.
-
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component.JHEP Rep. 2023 Dec 30;6(4):100997. doi: 10.1016/j.jhepr.2023.100997. eCollection 2024 Apr. JHEP Rep. 2023. PMID: 38425450 Free PMC article.
-
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells.Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4281-6. doi: 10.1073/pnas.1000621107. Epub 2010 Feb 16. Proc Natl Acad Sci U S A. 2010. PMID: 20160099 Free PMC article.
References
-
- Seder RA, Mascola JR. In: The Vaccine Book. Bloom BR, Lambert PH, editors. Boston: Academic; 2003. pp. 51–72.
-
- Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: What we know, what we don't know, what we should know. Nat Med. 2004;10:806–810. - PubMed
-
- Saul A, Nussenzweig V, Nussenzweig RS. In: Novel Vaccination Strategies. Kaufmann SHE, editor. New York: Wiley-Vch Verlag GmbH & Co; 2004. pp. 479–503.
-
- Spellberg B, Edwards JE., Jr Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76–102. - PubMed
-
- Darrah PA, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13:843–850. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials